Corline Biomedical AB

OM:CLBIO Voorraadrapport

Marktkapitalisatie: SEK 177.1m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Corline Biomedical Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Henrik Nittmar

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO16.8yrs
Eigendom CEO2.6%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur7.8yrs

Recente managementupdates

Recent updates

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Aug 24
Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

Mar 15
We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow

Nov 26
We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Jun 22
Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth

Feb 16
We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth

Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth

Jun 14
Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth

Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation

Feb 28
Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation

CEO

Henrik Nittmar (58 yo)

16.8yrs

Tenure

Dr. Henrik Nittmar, Ph. D., has been the Chief Executive Officer of Corline Biomedical AB (publ) (alternate name Corline Systems AB) since 2008. Dr. Nittmar works as an Investment Manager for a select numb...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Thomas Lifvendahl
Non-Executive Director2.8yrsgeen gegevensgeen gegevens
Lars Sunnanväder
Non-Executive Director19.8yrsgeen gegevens9.82%
SEK 17.4m
Gunilla Ekstrom
Independent Non-Executive Director7.8yrsSEK 105.00kgeen gegevens
Adam Dahlberg
Chairman19.8yrsgeen gegevens26.68%
SEK 47.3m
Henrik Krook
Independent Non-Executive Director7.4yrsSEK 105.00kgeen gegevens
Rutger Ploeg
Scientific Advisor7.8yrsgeen gegevensgeen gegevens
Magnus Nilsson
Independent Non-Executive Director4.8yrsgeen gegevensgeen gegevens

7.8yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CLBIO wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.8 jaar).